Literature DB >> 7523446

The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis.

C J Sindic1, P Monteyne, E C Laterre.   

Abstract

A highly sensitive antigen-mediated capillary blot technique was developed for the detection of virus-specific oligoclonal IgG in paired CSF and serum samples from patients with various neurological diseases. In multiple sclerosis, intrathecal synthesis of oligoclonal antibodies was present against measles (70%), rubella (60%), varicella zoster (40%) and mumps (30%); in most cases (75%), such synthesis involved two or more viruses. In contrast, antibodies against a non-neurotropic virus (cytomegalovirus) were rarely produced in CSF from MS patients (5%). However, this 'polyspecific' reaction was not restricted to MS samples but was also observed in neurolupus and in the late phase of infectious diseases of the central nervous system. These anti-viral antibodies could be produced without de novo replication of the corresponding viral genome and are likely mere bystanders of an ongoing immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523446     DOI: 10.1016/0165-5728(94)90233-x

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  23 in total

Review 1.  The MRZ reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature.

Authors:  S Jarius; P Eichhorn; D Franciotta; H F Petereit; G Akman-Demir; M Wick; B Wildemann
Journal:  J Neurol       Date:  2016-12-22       Impact factor: 4.849

Review 2.  The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Cinque; G M Cleator; T Weber; P Monteyne; C J Sindic; A M van Loon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-10       Impact factor: 10.154

Review 3.  Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

Authors:  S A Misbah
Journal:  Clin Exp Immunol       Date:  2017-03-27       Impact factor: 4.330

Review 4.  Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.

Authors:  Gregory P Owens; Jeffrey L Bennett
Journal:  Mult Scler       Date:  2012-06-08       Impact factor: 6.312

Review 5.  Low intrathecal antibody production despite high seroprevalence of Epstein-Barr virus in multiple sclerosis: a review of the literature.

Authors:  Klemens Ruprecht; Brigitte Wildemann; Sven Jarius
Journal:  J Neurol       Date:  2017-11-02       Impact factor: 4.849

Review 6.  Immune response in progressive multifocal leukoencephalopathy: an overview.

Authors:  T Weber; F Weber; H Petry; W Lüke
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

Review 7.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01

8.  Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients.

Authors:  Martin Stangel; Klemens Ruprecht; Brigitte Wildemann; Sven Jarius; Florence Pache; Peter Körtvelyessy; Ilijas Jelčić; Mark Stettner; Diego Franciotta; Emanuela Keller; Bernhard Neumann; Marius Ringelstein; Makbule Senel; Axel Regeniter; Rea Kalantzis; Jan F Willms; Achim Berthele; Markus Busch; Marco Capobianco; Amanda Eisele; Ina Reichen; Rick Dersch; Sebastian Rauer; Katharina Sandner; Ilya Ayzenberg; Catharina C Gross; Harald Hegen; Michael Khalil; Ingo Kleiter; Thorsten Lenhard; Jürgen Haas; Orhan Aktas; Klemens Angstwurm; Christoph Kleinschnitz; Jan Lewerenz; Hayrettin Tumani; Friedemann Paul
Journal:  J Neuroinflammation       Date:  2022-01-20       Impact factor: 8.322

9.  IgG antibodies against measles, rubella, and varicella zoster virus predict conversion to multiple sclerosis in clinically isolated syndrome.

Authors:  Johannes Brettschneider; Hayrettin Tumani; Ulrike Kiechle; Rainer Muche; Gayle Richards; Vera Lehmensiek; Albert C Ludolph; Markus Otto
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

10.  Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.

Authors:  Georgina Galicia; Bryant Boulianne; Natalia Pikor; Alberto Martin; Jennifer L Gommerman
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.